(PBI)

Role: EVP/Gen Counsel & Corp Sec
Signature: Elisabeth Weinberg, as attorney in fact for Lauren Freeman-Bosworth
Issuer symbol: PBI
Transactions as of: 27 Feb 2026
Net transactions value: -$137,460
Form type: 4
Filing time: 03 Mar 2026, 17:16:50 UTC
Previous filing: 27 Feb 2026
Next filing: 05 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Freemen-Bosworth Lauren	EVP/Gen Counsel & Corp Sec	27 WATERVIEW DRIVE, SHELTON	Elisabeth Weinberg, as attorney in fact for Lauren Freeman-Bosworth	03 Mar 2026	0002018873

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PBI	Common Stock	Options Exercise	$167,720	+28,000	+89%	$5.99	59,493	27 Feb 2026	Direct	F1
transaction	PBI	Common Stock	Sale	$302,307	-28,253	-47%	$10.70	31,240	27 Feb 2026	Direct	F1, F2
transaction	PBI	Common Stock	Sale	$2,873	-271	-0.87%	$10.60	30,969	02 Mar 2026	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PBI	Stock Option	Options Exercise	$0	-28,000	-93%	$0.000000	2,000	27 Feb 2026	Common Stock	28,000	$5.99	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	The stock option exercises and broker-assisted sales transactions reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 31, 2025 during the Company's open window period (the "Trading Plan").
F2	The price reported here is a weighted average price. The transaction was executed over multiple trades at prices ranging from $10.57 to $10,84, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Content

The stock option exercises and broker-assisted sales transactions reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 31, 2025 during the Company's open window period (the "Trading Plan").

The price reported here is a weighted average price. The transaction was executed over multiple trades at prices ranging from $10.57 to $10,84, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.